{"transactions":[{"id":725383,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-26T18:27:02.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":36000,"price":1.22,"value":43920.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option vests in monthly installments over the three-year period following the grant date, subject to continued service through such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Initial grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in monthly installments over the three-year period following the grant date, subject to continued service through such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The option vests in monthly installments over the three-year period following the grant date, subject to continued service through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The option vests in monthly installments over the three-year period following the grant date, subject to continued service through such date."}],"balance_after":36000,"derivative":{"exercise_price":1.22,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001753926-26-001081","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392626001081/form4.xml","form_type":"4"}},{"id":749331,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right-to-Buy)","published_at":"2026-06-04T21:47:00.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":77586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest in full, subject to the Director's continued service, the earlier of (1) the first anniversary of the grant date and (2) the date of the Company's next annual meeting of shareholders."}],"balance_after":77586,"derivative":{"exercise_price":1.39,"exercise_date":"2027-06-02","expiration_date":"2036-06-02","underlying":"Class A Common Stock","underlying_shares":77586},"source":{"system":"sec-edgar","filing":"0001615594-26-000043","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1344412/000161559426000043/primary_doc.xml","form_type":"4"}},{"id":1133118,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right-to-Buy)","published_at":"2025-05-27T19:22:08.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":39301,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest in full, subject to the Director's continued service, the earlier of (1) the first anniversary of the grant date and (2) the date of the Company's next annual meeting of shareholders"}],"balance_after":39301,"derivative":{"exercise_price":2.77,"exercise_date":"2026-05-22","expiration_date":"2035-05-22","underlying":"Class A Common Stock","underlying_shares":39301},"source":{"system":"sec-edgar","filing":"0001615594-25-000077","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1344412/000161559425000077/primary_doc.xml","form_type":"4"}},{"id":1352420,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right-to-Buy)","published_at":"2024-11-25T21:42:27.000Z","date":"2024-11-20","kind":"grant","planned":false,"acquired":true,"shares":14733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full, subject to Director's continued service, on the earlier of (1) the first anniversary of the date of the grant and (2) the date of the Company's next annual meeting of the shareholders."}],"balance_after":14733,"derivative":{"exercise_price":3.97,"exercise_date":"2025-11-20","expiration_date":"2034-11-20","underlying":"Class A Common Stock","underlying_shares":14733},"source":{"system":"sec-edgar","filing":"0001615594-24-000059","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1344412/000161559424000059/primary_doc.xml","form_type":"4"}},{"id":1891125,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-17T00:52:00.000Z","date":"2023-05-15","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable"}],"balance_after":217060,"derivative":{"exercise_price":9.41,"expiration_date":"2029-03-19","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001610717-23-000044","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1344412/000161071723000044/form4.xml","form_type":"4"}},{"id":1891124,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-17T00:52:00.000Z","date":"2023-05-15","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":9.41,"value":28230.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects 1,450 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt from Rule 16b-3."}],"balance_after":11045,"source":{"system":"sec-edgar","filing":"0001610717-23-000044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1344412/000161071723000044/form4.xml","form_type":"4"}},{"id":2015481,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-15T01:26:11.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of February 10, 2023 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company"}],"balance_after":50000,"derivative":{"exercise_price":20.24,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-23-003009","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1344412/000156761923003009/doc1.xml","form_type":"4"}},{"id":2077483,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-22T23:51:08.000Z","date":"2022-12-21","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on the first anniversary measured from January 7, 2019 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":220060,"derivative":{"exercise_price":9.41,"expiration_date":"2029-03-19","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001567619-22-021958","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1344412/000156761922021958/doc1.xml","form_type":"4"}},{"id":2077482,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-22T23:51:08.000Z","date":"2022-12-21","kind":"exercise","acquired":true,"shares":3000,"price":9.41,"value":28230.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects 1,595 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt from Rule 16b-3."}],"balance_after":6595,"source":{"system":"sec-edgar","filing":"0001567619-22-021958","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1344412/000156761922021958/doc1.xml","form_type":"4"}},{"id":2165207,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-07T00:41:18.000Z","date":"2022-09-01","kind":"grant","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 1, 2022 (the \"Vesting Commencement Date\") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company."}],"balance_after":60000,"derivative":{"exercise_price":8.04,"expiration_date":"2032-08-31","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001567619-22-017101","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1344412/000156761922017101/doc1.xml","form_type":"4"}},{"id":2413158,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-03T22:43:39.000Z","date":"2022-02-01","kind":"grant","acquired":false,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of February 1, 2022 (the \"Vesting Commencement Date\") while the grantee remains a service provider to the Company."}],"balance_after":65000,"derivative":{"exercise_price":15.78,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001567619-22-002468","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1344412/000156761922002468/doc1.xml","form_type":"4"}},{"id":2749390,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-14T20:32:02.000Z","date":"2021-04-12","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is partially vested and will vest with respect to the remaining shares in equal monthly installments until fully vested on January 7, 2023."}],"balance_after":223060,"derivative":{"exercise_price":9.41,"expiration_date":"2029-03-19","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001567619-21-008045","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1344412/000156761921008045/doc1.xml","form_type":"4"}},{"id":2749389,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-14T20:32:02.000Z","date":"2021-04-12","kind":"exercise","acquired":true,"shares":1000,"price":9.41,"value":9410.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001567619-21-008045","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1344412/000156761921008045/doc1.xml","form_type":"4"}},{"id":2796496,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-10T21:04:54.000Z","date":"2021-03-08","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 8, 2021 (the \"Vesting Commencement Date\") while the grantee remains a service provider to the Company."}],"balance_after":70000,"derivative":{"exercise_price":41.66,"expiration_date":"2031-03-07","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001567619-21-005966","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1344412/000156761921005966/doc1.xml","form_type":"4"}},{"id":3974325,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer & SVP"}}],"security":"Common stock","published_at":"2018-04-04T00:35:22.000Z","date":"2018-03-31","kind":"tax_withholding","acquired":false,"shares":6975,"price":6.59,"value":45965.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock forfeited to meet the tax liability triggered by the vesting of such restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount does not include any unvested restricted stock previously reported on Form 4 by the reporting person."}],"balance_after":74447,"source":{"system":"sec-edgar","filing":"0001179110-18-005346","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000117911018005346/edgar.xml","form_type":"4"}},{"id":4125382,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer & SVP"}}],"security":"Stock Options","published_at":"2017-12-21T00:18:19.000Z","date":"2017-12-18","kind":"disposition_to_issuer","acquired":true,"shares":54200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These stock options were forfeited pursuant to a Transition and Consulting Agreement with the Issuer which was effective as of December 18, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options were exercisable in 48 equal monthly installments from February 8, 2017."}],"balance_after":0,"derivative":{"exercise_price":17.09,"expiration_date":"2027-02-08","underlying":"Common Stock","underlying_shares":54200},"source":{"system":"sec-edgar","filing":"0001179110-17-015749","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000117911017015749/edgar.xml","form_type":"4"}},{"id":4125381,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer & SVP"}}],"security":"Stock Options","published_at":"2017-12-21T00:18:19.000Z","date":"2017-12-18","kind":"disposition_to_issuer","acquired":true,"shares":92500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These stock options were forfeited pursuant to a Transition and Consulting Agreement with the Issuer which was effective as of December 18, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options were exercisable in 48 equal monthly installments from February 2, 2016."}],"balance_after":0,"derivative":{"exercise_price":16.07,"expiration_date":"2026-02-11","underlying":"Common Stock","underlying_shares":92500},"source":{"system":"sec-edgar","filing":"0001179110-17-015749","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000117911017015749/edgar.xml","form_type":"4"}},{"id":4125380,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer & SVP"}}],"security":"Stock Options","published_at":"2017-12-21T00:18:19.000Z","date":"2017-12-18","kind":"disposition_to_issuer","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These stock options were forfeited pursuant to a Transition and Consulting Agreement with the Issuer which was effective as of December 18, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options were exercisable in 48 equal monthly installments from February 4, 2015."}],"balance_after":0,"derivative":{"exercise_price":17.61,"expiration_date":"2025-02-04","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001179110-17-015749","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000117911017015749/edgar.xml","form_type":"4"}},{"id":4143043,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer & SVP"}}],"security":"Common stock","published_at":"2017-12-06T01:18:49.000Z","date":"2017-12-01","kind":"tax_withholding","acquired":false,"shares":10336,"price":7.11,"value":73488.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock forfeited to meet the tax liability triggered by the vesting of such restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount does not include any unvested restricted stock previously reported on Form 4 by the reporting person."}],"balance_after":58949,"source":{"system":"sec-edgar","filing":"0001179110-17-014989","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000117911017014989/edgar.xml","form_type":"4"}},{"id":4362624,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer & SVP"}}],"security":"Restricted Stock Units","published_at":"2017-04-05T00:12:35.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units are scheduled to vest 50% on March 31, 2018 and 50% on March 31, 2019, assuming continued employment through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units are scheduled to vest 50% on March 31, 2018 and 50% on March 31, 2019, assuming continued employment through the applicable vesting date."}],"balance_after":40000,"derivative":{"underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001179110-17-005722","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000117911017005722/edgar.xml","form_type":"4"}},{"id":4362623,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer & SVP"}}],"security":"Common stock","published_at":"2017-04-05T00:12:35.000Z","date":"2017-04-02","kind":"tax_withholding","acquired":false,"shares":940,"price":12.55,"value":11797.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock forfeited to meet the tax liability triggered by the vesting of such restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount does not include any unvested restricted stock previously reported on Form 4 by the reporting person."}],"balance_after":41785,"source":{"system":"sec-edgar","filing":"0001179110-17-005722","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000117911017005722/edgar.xml","form_type":"4"}},{"id":4457979,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer & SVP"}}],"security":"Stock Options","published_at":"2017-02-11T00:38:01.000Z","date":"2017-02-08","kind":"grant","acquired":true,"shares":54200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options are exercisable in 48 equal monthly installments."}],"balance_after":54200,"derivative":{"exercise_price":17.09,"expiration_date":"2027-02-08","underlying":"Common Stock","underlying_shares":54200},"source":{"system":"sec-edgar","filing":"0001179110-17-002202","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000117911017002202/edgar.xml","form_type":"4"}},{"id":4457978,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer & SVP"}}],"security":"Restricted Stock Units","published_at":"2017-02-11T00:38:01.000Z","date":"2017-02-08","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units are scheduled to vest 25% on December 1, 2017, 25% on December 1, 2018, 25% on December 1, 2019, and 25% on December 1, 2020, assuming continued employment through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units are scheduled to vest 25% on December 1, 2017, 25% on December 1, 2018, 25% on December 1, 2019, and 25% on December 1, 2020, assuming continued employment through the applicable vesting date."}],"balance_after":23000,"derivative":{"underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001179110-17-002202","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000117911017002202/edgar.xml","form_type":"4"}},{"id":4531997,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer & SVP"}}],"security":"Common stock","published_at":"2016-12-06T23:56:08.000Z","date":"2016-12-01","kind":"tax_withholding","acquired":false,"shares":10853,"price":18.55,"value":201323.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock forfeited to meet the tax liability triggered by the vesting of such restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount does not include any unvested restricted stock previously reported on Form 4 by the reporting person."}],"balance_after":40225,"source":{"system":"sec-edgar","filing":"0001179110-16-032498","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000117911016032498/edgar.xml","form_type":"4"}},{"id":4556019,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer & SVP"}}],"security":"Common Stock","published_at":"2016-11-15T21:43:23.000Z","date":"2016-11-14","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"57,038 stock options were granted on February 18, 2014 and were exercisable in 48 equal monthly installments."}],"balance_after":48741,"derivative":{"exercise_price":12.69,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001179110-16-031609","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000117911016031609/edgar.xml","form_type":"4"}},{"id":4556018,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer & SVP"}}],"security":"Common Stock","published_at":"2016-11-15T21:43:23.000Z","date":"2016-11-14","kind":"sale","acquired":false,"shares":5000,"price":20.84,"value":104200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to a 10b5-1 plan adopted on March 12, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares at each price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount does not include any unvested restricted stock previously reported on Form 4 by the reporting person."}],"balance_after":21680,"source":{"system":"sec-edgar","filing":"0001179110-16-031609","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000117911016031609/edgar.xml","form_type":"4"}},{"id":4556017,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":35118,"kind":"person","name":"Moretti August J","position":1,"cik":"0001344412","reported_name":"Moretti August J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer & SVP"}}],"security":"Common Stock","published_at":"2016-11-15T21:43:23.000Z","date":"2016-11-14","kind":"exercise","acquired":true,"shares":5000,"price":12.69,"value":63450.0,"ownership":{"direct":true},"balance_after":26680,"source":{"system":"sec-edgar","filing":"0001179110-16-031609","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000117911016031609/edgar.xml","form_type":"4"}}]}